Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • « Prev · Page [31]
NCT ID: NCT00190125 Not yet recruiting - Inflammation Clinical Trials

The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to explore the severity of malnutrition and inflammation in Taiwanese hemodialysis patients.

NCT ID: NCT00173992 Not yet recruiting - Stroke Clinical Trials

Balance Recovery and Training on Fall Prevention in Stroke

Start date: September 2005
Phase: N/A
Study type: Interventional

The specific aims of this research are delineated as the following: Aim 1: To investigate the neuromuscular and biomechanical mechanisms of the emerging processes of proactive and reactive balance control during sitting and standing in patients with stroke at different stages of the recovery course. Aim 2: To determine the relationships between brain lesion sites and the recovery patterns of reactive and proactive balance control mechanisms in patients with stroke. Aim 3: To determine the relationships between the impairments in reactive and proactive balance control mechanisms and functional outcome as well as fall incidence in patients following stroke. Aim 4: To investigate the efficacy of different training regimens in improving reactive and proactive balance control strategies and in preventing falls in stroke patients with different brain lesion sites. Principally, three hypotheses are to be tested: Hypothesis 1:The emerging processes and recovery patternes of proactive and reactive balance control may be different among stroke patients with different brain lesion locations. Hypothesis 2:There are positive correlations between the level of impairments in reactive and proactive balance control mechanisms and functional outcome as well as fall incidence in patients following stroke. Hypothesis 3:Training regimens that could best facilitate the emergence or improvement in reactive and proactive balance control strategies are different.

NCT ID: NCT00173849 Not yet recruiting - Oral Cancer Clinical Trials

The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma

Start date: January 2006
Phase: N/A
Study type: Observational

Investigate the role of SDF-1/CXCR4 in the metastasis of oral squamous cell carcinoma

NCT ID: NCT00173732 Not yet recruiting - Clinical trials for Preimplantation Genetic Diagnosis (PGD)

Establishment of Comprehensive Genetic Analysis From a Single Cell

Start date: September 2005
Phase: N/A
Study type: Observational

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and reduce spontaneous abortions after implantation. The principal problems in single cell PCR include amplification failure, ADO and contamination. Multiple displacement amplification (MDA) is a technique used in the amplification of very low amounts of DNA and reported to yield large quantities of high-quality DNA. By this approach, the diagnosis of gene disorders form single cell will be more accurate and reliable.

NCT ID: NCT00173667 Not yet recruiting - Hypertension Clinical Trials

A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension

Start date: n/a
Phase: Phase 4
Study type: Interventional

Objective: - To evaluate the antihypertensive efficacy of two brands of nifedipine 30mg in patients with hypertension. - To assess the safety of 8 weeks of therapy with two brands of nifedipine 30mg in patients with hypertension. - To study flow-mediated dilatation and oxidative stress in nonsmoker with essential hypertension but without diabetes mellitus or dyslipidemia. Study Design: - Head-to-head, randomized and parallel design. - A total of 60 patients with a clinically confirmed diagnosis of hypertension will provide 30 available patients in each treatment group. - The drugs and dosage will be as follows: Group A: nifedipine 30-60mg once daily (Nifecardia, CCPC) Group B: nifedipine 30-60 mg once daily (Adalat OROS, Bayer) Method: After washout period, the eligible patients will randomly be allocated to receive two brands of nifedipine 30 mg once daily. Each patient will receive two times of ambulatory blood pressure measurement (ABPM) at both entrance and final stages of the study. The patients will also undergo complete clinical evaluation. Therapy dosage will be started at a dose of nifedipine 30 mg once daily. Dosage will be adjusted if systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 mmHg by office measurement after 4 weeks of treatment. Nifedipine will be increased to 60 mg once daily. The Ambulatory blood pressure measurement will be set to take reading at 1-hour intervals during the 24 hours assessment. Physical examination included the measurement of heart rate and blood pressure. The value will be read on Visit 1 and 3-12 hours after the last dose of nifedipine. Routine laboratory test includes hematology, blood chemistry and urinalysis. Hematology test and fasting blood chemistry test will be measured immediately before the start of treatment and after 8 weeks’ treatment or at time of discontinuation. Thiobarbituric acid–reactive substances (TBARS) in patient plasma were measured for oxidative stress and endothelium-dependent flow-mediated vasodilation will also be evaluated. Possible concomitant medication will remain constant throughout the study. The physician will question the patients as to their compliance at each visit. If compliance dose not reach 80%, the subject will be dropped out.

NCT ID: NCT00173303 Not yet recruiting - Breast Cancer Clinical Trials

The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective Study

Start date: January 2006
Phase: N/A
Study type: Observational

The purpose of this study is to evalute whether CAD (computer-aided detection) in FFDM (full-field digital mammography) can facilitate the detection rate of breast cancer on mammography compared with FFDM without CAD.

NCT ID: NCT00172302 Not yet recruiting - Clinical trials for Kidney Failure, Chronic

Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?

Start date: November 2005
Phase: N/A
Study type: Interventional

Intravenous vitamin C may improve skin hyperpigmentation in chronic hemodialysis patients

NCT ID: NCT00154635 Not yet recruiting - Clinical trials for Dementia, Alzheimer Type

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease

Start date: September 2005
Phase: Phase 2
Study type: Interventional

A Double-blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of DCB-AD1 in Patients with Mild to Moderate Alzheimer’s Disease. Because of the limitation of the sample size we could expect but a positive trend of the efficacy unless the effect size of DCB-AD1 is larger than 0.63. This information will provide us clue if further clinical investigation such as a phase III study should be carried out in an even larger scale. We also should be able to obtain valuable experience on the adverse effect of prolonged (24-week) use of Fo-ti.